Results 1 to 10 of about 59,924 (341)
Computational drug repositioning with attention walking [PDF]
Drug repositioning aims to identify new therapeutic indications for approved medications. Recently, the importance of computational drug repositioning has been highlighted because it can reduce the costs, development time, and risks compared to ...
Jong-Hoon Park, Young-Rae Cho
doaj +6 more sources
Drug repositioning based on individual bi-random walks on a heterogeneous network [PDF]
Background Traditional drug research and development is high cost, time-consuming and risky. Computationally identifying new indications for existing drugs, referred as drug repositioning, greatly reduces the cost and attracts ever-increasing research ...
Yuehui Wang +4 more
doaj +2 more sources
Drug Repositioning in Friedreich Ataxia [PDF]
Friedreich ataxia is a rare neurodegenerative disorder caused by insufficient levels of the essential mitochondrial protein frataxin. It is a severely debilitating disease that significantly impacts the quality of life of affected patients and reduces ...
Alessandra Rufini +6 more
doaj +4 more sources
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
Repositioning or repurposing drugs account for a substantial part of entering approval pipeline drugs, which indicates that drug repositioning has huge market potential and value.
Sha Zhu +3 more
doaj +3 more sources
Some Aspects and Convergence of Human and Veterinary Drug Repositioning [PDF]
Drug innovation traditionally follows a de novo approach with new molecules through a complex preclinical and clinical pathway. In addition to this strategy, drug repositioning has also become an important complementary approach, which can be shorter ...
Patrik Mag +3 more
doaj +2 more sources
Network mirroring for drug repositioning [PDF]
Background Although drug discoveries can provide meaningful insights and significant enhancements in pharmaceutical field, the longevity and cost that it takes can be extensive where the success rate is low.
Sunghong Park +2 more
doaj +4 more sources
BackgroundDrug repositioning is a pivotal strategy in pharmaceutical research, offering accelerated and cost-effective therapeutic discovery. However, biomedical information relevant to drug repositioning is often complex, dispersed, and underutilized ...
Hongyu Kang +5 more
doaj +2 more sources
Antiretroviral Drug Repositioning for Glioblastoma. [PDF]
Outcomes for glioblastoma (GBM) remain poor despite standard-of-care treatments including surgical resection, radiation, and chemotherapy. Intratumoral heterogeneity contributes to treatment resistance and poor prognosis, thus demanding novel therapeutic approaches.
Rivas SR +16 more
europepmc +3 more sources
Biology-Informed Matrix Factorization: An AI-Driven Framework for Enhanced Drug Repositioning. [PDF]
Wang Y, Wang Y, Hu Y, Wang J.
europepmc +2 more sources
A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus [PDF]
Drug repositioning is a strategy for identifying new applications of an existing drug that has been previously proven to be safe. Based on several examples of drug repositioning, we aimed to determine the methodologies and relevant steps associated with ...
Suehyun Lee, Seongwoo Jeon, Hun-Sung Kim
doaj +1 more source

